Home
About us
Our team
Get involved
Resources
News
Contact
Patient Information
Patient Trials and the Disease Registry
Home
About us
Our team
Get involved
Resources
News
Contact
Patient Information
Patient Trials and the Disease Registry
Donate
News
Latest news
In Focus: From the lab to the clinic in New Zealand’s first CAR T-cell therapy clinical trial
March 9, 2023
News
Dr Ken Romeril, Multiple Myeloma founder, Member of the NZ Order of Merit, advocates for the desperate need for access to modern medicines for myeloma sufferers.
December 11, 2022
News
BLOOD CANCER PATIENTS IMPLORE PHARMAC TO FUND DESPERATELY NEEDED MEDICINE
September 7, 2022
News
Multiple Myeloma Research Review
August 23, 2022
Article of the week
,
News
,
Research
,
Research Review
Newsletter: Winter 2022
August 22, 2022
Newsletters
Rachel Smalley: 1,000 kiwis will die while Pharmac takes eight months to make a decision
August 17, 2022
Article of the week
,
Helpful videos
,
News
Multiple Myeloma Queenstown Summit
June 29, 2022
Article of the week
,
News
,
Upcoming events
Multiple Myeloma Research Review
May 23, 2022
Article of the week
,
News
,
Research
,
Research Review
Multiple Myeloma CEO, Dr Ken Romeril, on The AM Show this morning, calling for a release of the independent report on Pharmac
May 11, 2022
News
DOCTOR CALLS ON MINISTER LITTLE TO RELEASE ‘BURIED’ INDEPENDENT REPORT ON PHARMAC
May 11, 2022
Article of the week
,
News
Dr Ken Romeril, of Wellington, receives his MNZM for services to haematology.
May 4, 2022
Article of the week
,
News
Updates on the Rapidly Changing Therapeutic Landscape in Multiple Myeloma
May 1, 2022
Article of the week
,
News
Multiple Myeloma Media Release
April 28, 2022
Article of the week
,
News
Decision on access criteria for oral COVID-19 treatments
April 24, 2022
Covid-19
,
News
FRAIL-M TRIALS FOR TRANSPLANT INELIGIBLE MYELOMA (PHASE I/II)
April 19, 2022
Article of the week
,
News
,
Research
Honoured haematologist and HIV pioneer fears he won’t see action from ‘glacial’ Pharmac in his lifetime.
April 10, 2022
Article of the week
,
News
COVID-19 information for patients and whānau with cancer.
March 25, 2022
Covid-19
,
News
Pharmac Review Final Report – Update
March 10, 2022
News
Newsletter: Autumn 2022
March 6, 2022
Newsletters
Endorsers of the ICBCC Patient Impact Statement
March 3, 2022
Article of the week
,
Covid-19
,
News
Myeloma Australia’s Medical and Scientific Advisory Group (MSAG), article of the week
February 17, 2022
Article of the week
,
News
CD38 directed therapy shows promise in Multiple Myeloma
February 16, 2022
News
Australians have limited awareness of blood cancers, – new survey
February 11, 2022
Helpful videos
,
News
Which haematology patients are at higher risk of COVID-19?
February 10, 2022
Covid-19
,
Helpful videos
,
News
Expert advice on preventing infection in multiple myeloma
February 9, 2022
News
Dr Ken Romeril – The Medicine Gap
November 29, 2021
News
Newsletter: Spring 2021
November 29, 2021
Newsletters
Seminar: Treatment of newly diagnosed myeloma – when things don’t go to plan
November 22, 2021
News
Myeloma NZ End of Year Function
November 22, 2021
News
,
Upcoming events
COVID mortality rate a concern in vaccinated blood cancer patients
November 17, 2021
Covid-19
,
News
Proactive fatigue screening and management called for in blood cancer patients
November 10, 2021
News
Covid-19: ‘Not fair’ unvaccinated will force mum with blood cancer to stay ‘locked’ in home for remaining years
October 29, 2021
Covid-19
,
News
,
Research
New Trial In Relapsed/refractory multiple myeloma
October 28, 2021
News
Paediatric oncology parents are pleased with quality of care despite pandemic
October 21, 2021
Covid-19
,
News
,
Research
PVd triplet therapy now on PBS for MM patients after first relapse
October 13, 2021
News
,
Research
ATAGI specifies which patients with haematological malignancy should have COVID-19 booster vax
October 13, 2021
Covid-19
,
News
,
Research
‘I am screwed if it comes back’: Experts concerned by Covid’s hidden impact on blood cancer treatments
September 27, 2021
Covid-19
,
News
,
Research
Myeloma Research Review – Issue 39
September 2, 2021
News
,
Research Review
Newsletter: Winter 2021
August 16, 2021
News
,
Newsletters
CANCELLED: National Patient Seminar – 13 November 2021
August 8, 2021
News
,
Past events
Distress doubles for blood cancer patients during pandemic
July 18, 2021
Covid-19
,
News
,
Research
Distress doubles for blood cancer patients during pandemic
July 14, 2021
Covid-19
,
News
Isatuximab another string in the bow for management of RRMM
June 22, 2021
News
,
Research
Wellington Patient Meeting 1 July
June 15, 2021
News
,
Past events
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
June 9, 2021
News
,
Research
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
June 9, 2021
News
,
Research
Donna’s Advice to Multiple Myeloma Patients
June 9, 2021
News
,
Research
Haematologist slams ‘treatment lottery’ for amyloidosis patients
June 9, 2021
News
When the new normal is far from normal. Jason Oxenham on combatting cancer
June 1, 2021
News
,
Research
PBAC blocks access to new myeloma drugs: Prof Andrew Spencer
May 18, 2021
News
,
Research